Gurlek, F., & Tasdemir, E. (2020). Is it an advantage or disadvantage to usage angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in COVID-19 patients?. International Journal of Research in Medical Sciences, 8(12), 4200–4205. https://doi.org/10.18203/2320-6012.ijrms20205289